Physician profile
Daniel H Sajewski
NPI 1669485041
$76,212.56
in general payments reported to CMS, 2019-2025
46 companies · $8,236 in 2025
The $8,236 reported for 2025 was more than what 99% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16K · 2020: $8,668 · 2021: $13K · 2022: $7,502 · 2023: $12K · 2024: $9,662 · 2025: $8,236.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $24K · Food and Beverage: $5,394 · Travel and Lodging: $546 · Education: $302 · Entertainment: $159.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $23,975.58 |
| Food and Beverage | $5,394.31 |
| Travel and Lodging | $545.62 |
| Education | $302.00 |
| Entertainment | $158.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cumberland Pharmaceuticals, INC. | $67,096.24 | 2019-2025 | Caldolor, Vibativ |
| Abbott Laboratories | $1,734.36 | 2019-2024 | Proclaim, Quadra Allure Mp |
| Abbvie INC. | $1,316.26 | 2021-2025 | Ubrelvy, Botox, Qulipta |
| Vertos Medical, INC. | $1,257.40 | 2019-2023 | Mild Device Kit |
| Acelrx Pharmaceuticals, INC. | $960.63 | 2020-2021 | |
| Scilex Pharmaceuticals INC. | $707.20 | 2019-2025 | Ztlido |
| Medtronic USA, INC. | $270.76 | 2019-2020 | |
| Biodelivery Sciences International, INC. | $260.97 | 2020-2021 | |
| Merck Sharp & Dohme LLC | $248.04 | 2019-2025 | Bridion, Verquvo |
| Vertex Pharmaceuticals Incorporated | $227.43 | 2024-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $221.96 | 2019-2022 | |
| Chiesi USA, INC. | $213.49 | 2019-2025 | Kengreal, Cleviprex |
| Collegium Pharmaceutical, INC. | $197.73 | 2022-2025 | Xtampza, Belbuca |
| Amgen INC. | $138.23 | 2019-2020 | |
| Allergan, INC. | $118.86 | 2021-2022 |
Show all 46 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $113.36 | 2021-2024 | Intellis Adaptivestim |
| Pacira Pharmaceuticals Incorporated | $111.71 | 2022-2024 | Iovera, Zilretta |
| Azurity Pharmaceuticals, INC. | $100.13 | 2023-2025 | Horizant, Horizant |
| Takeda Pharmaceuticals U.S.A., INC. | $73.92 | 2019-2020 | |
| Valinor Pharma, LLC | $56.25 | 2023-2024 | Movantik |
| Boston Scientific Corporation | $55.32 | 2022-2023 | Watchman Flx |
| Arbor Pharmaceuticals, INC. | $52.29 | 2019-2021 | |
| Avanos Medical | $51.79 | 2019-2020 | |
| Eagle Pharmaceuticals, INC. | $51.77 | 2023-2024 | |
| Relievant Medsystems, INC. | $49.56 | 2021-2022 | |
| Forte Bio-Pharma LLC | $48.66 | 2024-2025 | Prolate, Nalocet, Tanlor |
| Protega Pharmaceutials INC | $48.27 | 2025 | Roxybond |
| Depuy Synthes Sales INC. | $45.79 | 2021-2023 | Orthovisc |
| Painteq LLC | $45.39 | 2021 | |
| Virtus Pharmaceuticals LLC | $37.53 | 2021-2022 | |
| Astrazeneca Pharmaceuticals LP | $37.51 | 2019-2020 | |
| Hikma Pharmaceuticals USA | $31.61 | 2024 | Kloxxado |
| Si-Bone, INC. | $25.72 | 2021 | |
| Averitas Pharma INC. | $21.81 | 2024 | Qutenza |
| Bioventus LLC | $19.82 | 2023 | Gelsyn-3 |
| Almatica Pharma LLC | $18.13 | 2021 | |
| Saluda Medical Americas, INC. | $16.90 | 2024 | Evoke |
| Lilly USA, LLC | $16.81 | 2022 | |
| Lundbeck LLC | $16.17 | 2023 | Vyepti |
| Redhill Biopharma INC. | $15.93 | 2021 | |
| Ibsa Pharma INC. | $15.50 | 2021 | |
| Shionogi INC | $14.14 | 2019 | |
| Assertio Therapeutics, INC. | $13.70 | 2019 | |
| Grt US Holding, INC. | $13.37 | 2021 | |
| Pfizer INC. | $12.95 | 2019 | |
| Horizon Therapeutics Plc | $11.19 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Sajewski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.